Patent Application
20180313810
Analyte sensors are commonly used to monitor the level of an analyte in a body fluid. For example, diabetics use analyte sensors, e.g., in the form of analytical test strips, to monitor body glucose levels. Commonly, an analyte sensor is contacted with a bodily fluid and inserted into an analyte meter or other device capable of determining one or more analyte levels based on signals provided by the analyte sensor. The analyte sensor can be received by the analyte meter or other device either before or after a sample of body fluid is applied to the analyte sensor. The sensor receiving area of the device, commonly referred to as a “sensor port,” provides an opening in the device for insertion of the analyte sensor. Consequently, the sensor port also provides an opening from the outside environment to the interior of the device. This exposure to the outside environment via the sensor port creates the potential for contaminating materials to enter the device's interior. As such contamination may affect internal components and/or interfere with the analysis results, there is interest in developing sensor ports which limit the potential for contamination.
The present disclosure provides a contamination resistant sensor port which includes one or more sealing members positioned so as to limit and/or prevent internal contamination of the sensor port with fluids and/or particles present in the environment outside the sensor port.
In a first aspect, the present disclosure provides a sensor port, which includes a housing, wherein the housing includes a body and a protruding member. The protruding member defines an entry slot configured to receive an analyte sensor. The sensor port according to the first aspect also includes a first sealing member positioned on the protruding member and circumscribing the protruding member, wherein the first sealing member is configured to form a seal between the sensor port and an electrical device.
In one embodiment of the sensor port according to the first aspect, the body defines a first opening and a second opening. The sensor port includes a second sealing member positioned on the body of the housing such that a seal is formed over the first opening. The sensor port also includes a third sealing member positioned on the body of the housing such that a seal is formed over the second opening. In one such embodiment, the second and third sealing members each include an adhesive backing which provides for attachment to the body of the housing. In one embodiment, where the second and third sealing members each include an adhesive backing which provides for attachment to the body of the housing, the second and third sealing members each include polyimide film tape.
In one embodiment of the sensor port according to the first aspect, the protruding member includes a channel which circumscribes the protruding member, wherein the first sealing member is positioned in the channel In one such embodiment, the channel defines an oval.
In one embodiment of the sensor port according to the first aspect, the electrical device is an analyte meter. In one such embodiment, the analyte meter is a glucose meter. In one embodiment, where the analyte meter is a glucose meter, the analyte sensor is a glucose test strip.
In one embodiment of the sensor port according to the first aspect, the first sealing member is a compliant gasket material. In one such embodiment, the compliant gasket material includes an elastomeric material. In one embodiment, where the first sealing member is a compliant gasket material, the compliant gasket material is an o-ring.
In one embodiment of the sensor port according to the first aspect, the entry slot includes an internal beveled face.
In one embodiment of the sensor port according to the first aspect, the housing includes an injection molded plastic.
In one embodiment of the sensor port according to the first aspect, the housing includes a top portion and a bottom portion which are joined to form the sensor port.
In one embodiment of the sensor port according to the first aspect, the sensor port is integrated in and operably connected to an electrical device. In one such embodiment, the electrical device is an analyte meter. In one embodiment, the analyte meter is a glucose meter.
In another embodiment of the sensor port according to the first aspect, where the sensor port is integrated in and operably connected to an electrical device, the electrical device is an integrated continuous glucose monitor receiver.
In another embodiment of the sensor port according to the first aspect, where the sensor port is integrated in and operably connected to an electrical device, the electrical device is a medication delivery device. In one such embodiment, the medication delivery device is a pump. In one embodiment, the medication delivered by the medication delivery device is insulin.
In one embodiment of the sensor port according to the first aspect, the first sealing member provides a substantially fluid-tight seal between the sensor port and the electrical device.
In a second aspect, the present disclosure provides a medication delivery device, wherein the medication delivery device includes a sensor port. The sensor port includes a housing and a first sealing member. The housing includes a body and a protruding member, the protruding member defining an entry slot configured to receive an analyte sensor. The first sealing member is positioned on the protruding member and circumscribes the protruding member. The first sealing member forms a seal between the sensor port and the medication delivery device.
In one embodiment of the medication delivery device according to the second aspect, the body defines a first opening and a second opening. The sensor port includes a second sealing member positioned on the body of the housing such that a seal is formed over the first opening. The sensor port also includes a third sealing member positioned on the body of the housing such that a seal is formed over the second opening. In one such embodiment, the second and third sealing members each include an adhesive backing which provides for attachment to the body of the housing. In one embodiment, where the second and third sealing members each include an adhesive backing which provides for attachment to the body of the housing, the second and third sealing members each include polyimide film tape.
In one embodiment of the medication delivery device according to the second aspect, the protruding member includes a channel which circumscribes the protruding member, wherein the first sealing member is positioned in the channel In one such embodiment, the channel defines an oval.
In one embodiment of the medication delivery device according to the second aspect, the analyte sensor is a glucose test strip.
In one embodiment of the medication delivery device according to the second aspect, the first sealing member is a compliant gasket material. In one such embodiment, the compliant gasket material comprises an elastomeric material. In one embodiment, where the first sealing member is a compliant gasket material, the compliant gasket material is an o-ring.
In one embodiment of the medication delivery device according to the second aspect, the entry slot includes an internal beveled face.
In one embodiment of the medication delivery device according to the second aspect, the housing includes an injection molded plastic.
In one embodiment of the medication delivery device according to the second aspect, the housing includes a top portion and a bottom portion which are joined to form the sensor port.
In one embodiment of the medication delivery device according to the second aspect, the medication delivery device is a pump. In one embodiment, the medication delivered by the medication delivery device is insulin.
In one embodiment of the medication delivery device according to the second aspect, the first sealing member provides a substantially fluid-tight seal between the sensor port and the medication delivery device.
These and other objects, features and advantages of the present disclosure will become more fully apparent from the following detailed description of the embodiments, the appended claims and the accompanying drawings.
The invention is best understood from the following detailed description when read in conjunction with the accompanying drawings. It is emphasized that, according to common practice, the various features of the drawings are not necessarily to-scale. The dimensions of the various features are arbitrarily expanded or reduced for clarity. Included in the drawings are the following figures:
Before the present invention is further described, it is to be understood that this invention is not limited to particular embodiments described, as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges, and are also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.
As used herein and in the appended claims, the singular forms “a,” “and,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation.
The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
As summarized above, the present disclosure is directed to a splash-proof sensor port which includes one or more sealing members positioned so as to prevent internal contamination of the sensor port with fluids and/or particles present in the environment outside the sensor port. In some embodiments, the sensor port may be included in, e.g., integrated with, an analyte meter or monitoring system, e.g., an in vitro analyte meter or an in vivo analyte monitoring system. Analyte meters and analyte monitoring systems suitable for use with the disclosed sensor ports include, for example, those available from Abbott Diabetes Care Inc. (Alameda, Calif.). Analyte meters may be electrochemical or optical meters, and may be configured to determine the level of one or more analytes, where analytes of interest include, but are not limited to, glucose, blood β-ketone, ketone bodies, lactate, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin, in sample of body fluid. Analyte meters may also be configured to determine the concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be determined and the like, in a sample of body fluid.
Integration with Analyte Meters and/or Analyte Monitoring Systems
In certain embodiments, sensor ports according to the present disclosure are integrated with analyte meters and/or analyte monitoring systems. For example, a sensor port according to the present disclosure may be integrated with a FreeStyle® blood glucose monitoring meter or a Precision® brand blood monitoring meter capable of monitoring glucose and ketones, or other such analytes. In addition, the disclosed sensor ports may find use in meters designed for use in a hospital or similar clinic environment where a single meter may be used for a plurality of patients. Such systems include, but are not limited to, Precision PCx® meters, FreeStyle Connect™ meters and Precision Xceed Pro™ meters manufactured by Abbott Diabetes Care Inc. (Alameda, Calif.).
In certain embodiments, the sensor ports may be integrated with a continuous analyte monitoring system. For example, a continuous glucose monitoring system may include a component that receives analyte data from a transcutaneously positioned or wholly implanted glucose sensor, and which component may be configured to communicate analyte results to the user, e.g., audibly by way of a display, or visually. The continuous monitoring system receiver may include a conventional blood glucose meter and therefore a port for accepting a glucose sensor, e.g., a glucose test strip. The conventional meter and test strip may be used to calibrate the continuous system, e.g., using one point calibration or other calibration protocol. For example, see U.S. Pat. No. 6,175,752, the disclosure of which is incorporated by reference herein.
It should be understood that description of sensor ports in connection with analyte meters includes stand-alone meters, as well those operably connected to, e.g., integrated with, continuous analyte monitoring systems. Exemplary sensors and meters and continuous analyte monitoring systems (sometimes referred to as in vivo systems) that may be utilized in connection with the disclosed sensor ports include sensors and meters such as those described in U.S. Pat. No. 7,041,468; U.S. Pat. No. 5,356,786; U.S. Pat. No. 6,175,752; U.S. Pat. No. 6,560,471; U.S. Pat. No. 5,262,035; U.S. Pat. No. 6,881,551; U.S. Pat. No. 6,121,009; U.S. Pat. No. 7,167,818; U.S. Pat. No. 6,270,455; U.S. Pat. No. 6,161,095; U.S. Pat. No. 5,918,603; U.S. Pat. No. 6,144,837; U.S. Pat. No. 5,601,435; U.S. Pat. No. 5,822,715; U.S. Pat. No. 5,899,855; U.S. Pat. No. 6,071,391; U.S. Pat. No. 6,120,676; U.S. Pat. No. 6,143,164; U.S. Pat. No. 6,299,757; U.S. Pat. No. 6,338,790; U.S. Pat. No. 6,377,894; U.S. Pat. No. 6,600,997; U.S. Pat. No. 6,773,671; U.S. Pat. No. 6,514,460; U.S. Pat. No. 6,592,745; U.S. Pat. No. 5,628,890; U.S. Pat. No. 5,820,551; U.S. Pat. No. 6,736,957; U.S. Pat. No. 4,545,382; U.S. Pat. No. 4,711,245; U.S. Pat. No. 5,509,410; U.S. Pat. No. 6,540,891; U.S. Pat. No. 6,730,200; U.S. Pat. No. 6,764,581; U.S. Pat. No. 6,299,757; U.S. Pat. No. 6,461,496; U.S. Pat. No. 6,503,381; U.S. Pat. No. 6,591,125; U.S. Pat. No. 6,616,819; U.S. Pat. No. 6,618,934; U.S. Pat. No. 6,676,816; U.S. Pat. No. 6,749,740; U.S. Pat. No. 6,893,545; U.S. Pat. No. 6,942,518; U.S. Pat. No. 6,514,718; U.S. Pat. No. 5,264,014; U.S. Pat. No. 5,262,305; U.S. Pat. No. 5,320,715; U.S. Pat. No. 5,593,852; U.S. Pat. No. 6,746,582; U.S. Pat. No. 6,284,478; U.S. Pat. No. 7,299,082; U.S. patent application Ser. No. 61/149,639, entitled “Compact On-Body Physiological Monitoring Device and Methods Thereof”, U.S. patent application Ser. No. 11/461,725, filed Aug. 1, 2006, entitled “Analyte Sensors and Methods”; U.S. patent application Ser. No. 12/495,709, filed Jun. 30, 2009, entitled “Extruded Electrode Structures and Methods of Using Same”; U.S. Patent Application Publication No. US2004/0186365; U.S. Patent Application Publication No. 2007/0095661; U.S. Patent Application Publication No. 2006/0091006; U.S. Patent Application Publication No. 2006/0025662; U.S. Patent Application Publication No. 2008/0267823; U.S. Patent Application Publication No. 2007/0108048; U.S. Patent Application Publication No. 2008/0102441; U.S. Patent Application Publication No. 2008/0066305; U.S. Patent Application Publication No. 2007/0199818; U.S. Patent Application Publication No. 2008/0148873; and U.S. Patent Application Publication No. 2007/0068807; the disclosures of each which are incorporated by reference herein.
Integration with Medication Delivery Devices and/or Systems
In some embodiments, the sensor ports disclosed herein may be included in, e.g., integrated with, a medication delivery system, e.g., an insulin pump module, such as an insulin pump or controller module thereof. Additional information regarding medication delivery devices and/or systems, such as, for example, integrated systems, is provided in U.S. Patent Application Publication No. US2006/0224141, published on Oct. 5, 2006, entitled “Method and System for Providing Integrated Medication Infusion and Analyte Monitoring System”, and U.S. Patent Application Publication No. US2004/0254434, published on Dec. 16, 2004, entitled “Glucose Measuring Module and Insulin Pump Combination,” the disclosure of each of which is incorporated by reference herein. Medication delivery devices which may be provided with an analyte meter which in turn includes a sensor port as described herein include, e.g., a needle, syringe, pump, catheter, inhaler, transdermal patch, or combination thereof. In some embodiments, the medication delivery device or system may be in the form of a drug delivery injection pen such as a pen-type injection device incorporated within the housing of an analyte meter. Additional information is provided in U.S. Pat. Nos. 5,536,249 and 5,925,021, the disclosure of each of which is incorporated by reference herein.
The medication delivery system may be used for injecting a dose of medication, such as insulin, into a patient based on a prescribed medication dosage, and may be automatically updated with dosage information received from an analyte meter. In another embodiment, the medication dosage of the medication delivery system may include manual entry of dosage changes made through, for example, an optional input unit coupled to the housing of an analyte meter. Medication dosage information associated with the medication delivery system may be displayed on an optional display unit disposed on a housing of an analyte meter.
Integration with Entry Slot Protectors
In some embodiments, the sensor ports described herein can be configured to work with (e.g., engage with or operate in connection with) additional mechanisms and/or devices designed to limit and/or prevent contamination of the internal areas of the sensor ports themselves or the internal areas of the electrical devices into which the sensor ports can be integrated. For example, mechanisms, devices and methods of protecting sensor port openings are described in U.S. Patent Application Publication No. US2008/0234559, and U.S. Patent Application Publication No. US2008/0119709, the disclosure of each of which is incorporated by reference herein. Sensor ports according to the present disclosure can also be configured to be replaceable and/or disposable, and/or configured so as to limit and/or prevent contamination of an electrical device in which the sensor port is integrated. Additional description is provided, for example, in U.S. application Ser. No. 12/495,662, filed Jun. 30, 2009, entitled “Strip Connectors for Measurement Devices;” the disclosure of which is incorporated by reference herein.
Exemplary Sensor Ports
Exemplary sensor ports are now described with reference to the Figures.
Entry slot 104 provides access to an internal region of body 102 and is configured to receive an analyte sensor, e.g., an analyte test strip (shown as an arrow, as depicted in
Sealing member 105 is configured to form a seal between the sensor port 100 and an electrical device (shown
The housing 101 can be formed from a variety of suitable materials. For example, a plastic material, e.g., an injection molded plastic material may be utilized. In some embodiments, the material is at least substantially rigid and of a sufficient hardness such that it will not deform under conditions of normal use, e.g., under normal analytical testing conditions. In one specific embodiment, a hot water moldable polyphthalamide (PPA) glass fiber material (available from RTP Company, Winona, Minn.) is utilized as the housing material.
In some embodiments, e.g., as shown in
In some embodiments, e.g., as shown in
In order to limit and/or prevent contamination of the internal region of sensor port 100, e.g., via the ingress of particles and/or fluids through opening 109 and/or 110, in some embodiments, a sealing member 107 is positioned on the body 102 of the housing 101 such that a seal is formed over the first opening 109. Another sealing member 108 is positioned on the body 102 of the housing 101 such that a seal is formed over the second opening 110. See, e.g.,
A variety of suitable materials may be used for sealing members 107 and 108, provided they are capable of limiting and/or preventing ingress of one or more fluids, particles, or other contaminants through openings 109 and 110. For example, suitable materials include, but are not limited to, one or more natural or synthetic polymers. In some embodiments, it may be desirable to use a material which includes a pre-applied adhesive, e.g., a silicone adhesive, in order to facilitate attachment of the sealing member to the body 102 of sensor port 100. Alternatively, a suitable adhesive can be applied separately. In one embodiment, a suitable material for use as sealing member 107 and/or 108 is polyimide film tape, such as that available from 3M Corporation (St. Paul, Minn.).
In some embodiments, as shown, for example, in
As illustrated in
Electrical contacts/leads 117 and 118 are optional electrical contacts/leads which can be configured such that upon insertion of an analyte sensor (not shown) optional electrical contacts/leads 117 and 118 contact an optional insertion monitor (not shown) positioned on the analyte sensor as described, for example, in U.S. Pat. No. 6,616,819, the disclosure of which is incorporated by reference herein; and/or a turn-on/selection monitor as described, for example, in U.S. application Ser. No. 12/431,672, filed Apr. 28, 2009, and entitled “Smart Sensor Ports and Methods of Using Same,” the disclosure of which is incorporated by reference herein. Additional description of insertion monitors and configurations suitable for use as turn-on/selection monitors is provided, for example, in U.S. Patent Application Publication No. US2006/0091006; U.S. Patent Application Publication No. US2008/0267823; U.S. Patent Application Publication No. US2009/0011449; U.S. Patent Application Publication No. US2008/0066305; U.S. Patent Application Publication No. US2008/0060196; U.S. Pat. No. 6,592,745; U.S. Pat. No. 6,143,164; U.S. Pat. No. 6,071,391; U.S. Pat. No. 6,503,381; and U.S. Pat. No. 6,893,545; the disclosures of each of which are incorporated by reference herein.
Electrode contacts/leads 120 and 121 are optional electrical contacts/leads which can be configured such that upon insertion of an analyte sensor (not shown) optional electrical contacts/leads 120 and 121 contact optional fill indicator electrode leads (not shown) of an analyte sensor (not shown), e.g., as described in U.S. Pat. No. 6,616,819, the disclosure of which is incorporated by reference herein.
The preceding merely illustrates the principles of the invention. It will be appreciated that those skilled in the art will be able to devise various arrangements which, although not explicitly described or shown herein, embody the principles of the invention and are included within its spirit and scope. Furthermore, all examples and conditional language recited herein are principally intended to aid the reader in understanding the principles of the invention and the concepts contributed by the inventors to furthering the art, and are to be construed as being without limitation to such specifically recited examples and conditions. Moreover, all statements herein reciting principles, aspects, and embodiments of the invention as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents and equivalents developed in the future, i.e., any elements developed that perform the same function, regardless of structure. The scope of the present invention, therefore, is not intended to be limited to the exemplary embodiments shown and described herein. Rather, the scope and spirit of present invention is embodied by the appended claims.
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14823777 | Aug 2015 | US |
| Child | 16014400 | US | |
| Parent | 12859055 | Aug 2010 | US |
| Child | 14823777 | US | |
| Parent | 12539217 | Aug 2009 | US |
| Child | 12859055 | US |
